Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4689-4692, Vol. 67, No. 9
Laboratorio de Imunologia, Faculdade de
Medicina do Triangulo Mineiro, 30, Frei Paulino, 38025-160, Uberaba,
MG, Brazil,1 and INSERM U399, Immunology
and Genetic of Parasitic Diseases, Faculté de Médecine de
Marseille, Université de la Méditerranée, Marseille,
France2
Received 29 December 1998/Returned for modification 12 February
1999/Accepted 18 June 1999
Human susceptibility to Schistosoma mansoni infections
is controlled by the SM1 locus on chromosome 5 in q31-q33. This genetic region encodes cytokines which regulate the development of helper T
lymphocytes. In the present work, a clonal analysis of CD4+
T lymphocytes of homozygous resistant and homozygous susceptible subjects was undertaken to evaluate whether SM1 controls helper T-cell
differentiation. Of 121 CD4+ T-cell clones (TCC) from three
susceptible (S) and three resistant (R) subjects, 68 proliferated when
stimulated by parasite antigens. Parasite-specific TCC derived from
susceptible subjects (33 STCC) produced 10- to 1,000-fold less
interleukin-4 and -5 than TCC from resistant subjects (25 RTCC). Clones
from both patient groups produced, however, the same amount of gamma
interferon. Parasite-specific STCC were type 1 helper (Th1) or Th0/1,
whereas RTCC were either Th2 or Th0/2. These results, together with the
localization of SM1 in 5q31-q33, indicate that the SM1 locus controls
the differentiation of Th2 lymphocytes.
In an area where schistosomiasis is
endemic, infections are heterogeneous, low and high levels of infection
can be recorded in subjects living in similar conditions of exposure to
the parasite. Since high levels of infection are a factor in disease
development, we and others have attempted to identify the reasons for
high levels of infection. It was shown that exposure to infection and environmental factors cannot fully account for the heterogeneity of
infection levels in an endemic population, and several studies have
indicated that infection intensities depended on individual resistance
and susceptibility levels (4, 9, 10, 30, 31). At least two
important components of the mechanisms of immune resistance,
immunoglobulin E (8, 11, 14, 24) and eosinophils (6,
15, 28) were identified, and resistance has been associated with
an increased production of interleukin-4 (IL-4) and IL-5 (7, 13,
20, 25). It was also observed that resistance depended on at
least two major factors: the age of the subjects (4, 5, 9,
10) and some inherited factor(s) that segregated in Brazilian
families as a major locus (SM1), which was mapped to chromosome 5 in
the q31-q33 region (2, 19). This result was confirmed in a
Senegalese population (21).
The 5q31-q33 region comprises a number of cytokine genes or genes
encoding cytokine receptors which are critical for helper T-cell (Th)
differentiation. This and the various reports showing that Th1 or Th2
lymphocytes play a central role in immunity to infectious pathogens
(1, 18) led us to test whether SM1 affected the
differentiation of Th1 or Th2 subsets. In a previous work, we showed
that resistance to infection was associated with Th2 or Th0/2 cells
(7); the aim of the present study was to evaluate Th-cell
subsets in the most susceptible subjects. The data indicate that
susceptibility is associated with a reduced ability to develop Th2 lymphocytes.
Patients.
This work was performed on Brazilians described
previously (9, 10) who were born and who lived in Caatinga
do Moura, a village of an area where S. mansoni is endemic.
These subjects had average or high levels of water contact; resistant
subjects (ages 10, 21, and 33 years) excreted fewer than 100 eggs/g of feces, whereas susceptible subjects (ages 15, 16, and 18 years) excreted more than 2,500 eggs/g. Parasitological and epidemiological data, including water contact, have been measured for several years and
are recorded as described previously (9, 10). Genotypes were
defined according to the transmission biallelic gene model predicted by
segregation analysis (2); this model takes into account the
influences of covariates such as age, sex, and water contacts.
Genotypes were confirmed by the linkage analysis data (19).
These subjects were either homozygous for the allele that determines
resistance to infection or were homozygous for the allele that
determines high rates of infection.
Preparation and characterization of properties of TCC.
T-cell clones (TCC) were derived from peripheral blood mononuclear
cells (PBMC) as previously described (7). Briefly, blood mononuclear cells were purified by centrifugation on a Ficoll-Hypaque cushion and cultured for 10 days with 10 U of recombinant human IL-2
(Chiron, Amsterdam, Holland) per ml and 10 µg of schistosome larval
extracts per ml prepared from mechanically transformed schistosomula
(9). T lymphocytes were cloned by limiting dilution with
irradiated PBMC, as feeder cells, in the presence of 5 µg of
phytohemagglutinin and 10 U of IL-2 per ml (7). The
specificity of TCC for schistosome extracts was tested in a
blastogenesis assay by using autologous PBMC as antigen-presenting
cells. TCC with a stimulation index of >2 were considered specific
(spTCC), whereas TCC with a lower stimulation index were considered to be of unknown specificity (uspTCC). To assess lymphokine production, TCC were stimulated with 10 ng of phorbol myristate acetate (PMA; Sigma, St. Quentin Fallavier, France) and 1 µg of anti-CD3 monoclonal antibody (MAb; Immunotech, Marseille, France) per ml. Because it was
not possible to bleed patients several times, stimulations with
parasite extracts were not used. Previous works have shown that
polyclonal stimulations do not modify the lymphokine secretion pattern
of established TCC (29).
Titration of cytokines.
Cytokines were measured by
enzyme-linked immunosorbent assay in 24-h culture supernatants.
Anti-IL-4 MAb, anti-gamma interferon (IFN- Statistical analysis.
The statistical analyses were
performed by using the Student's t test on the logarithm of
the cytokine concentrations (to approximate a normal distribution).
Schistosome-specific TCC from homozygous resistant subjects produce
more IL-4 and more IL-5 than specific TCC from homozygous susceptible
individuals.
TCC were derived from PBMC from three patients
homozygous for the allele(s) that determines resistance to infection
and from three patients homozygous for the allele(s) that determines
high-level infections. Of 121 CD4+ TCC, 68 (56%)
proliferated when stimulated with parasite larval extracts and were
termed specific TCC (spTCC); the others, referred to as clones of
unknown specificity (uspTCC), did not. There was no association between
clone proliferation and the resistant (R) or susceptible (S) status of
the donor.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic Control of Schistosome Infections by the
SM1 Locus of the 5q31-q33 Region Is Linked to Differentiation of Type 2 Helper T Lymphocytes
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) MAb (Mabtech), and
anti-IL-5 (Pharmingen) coated plates (Nunc) were incubated overnight
with dilutions of culture supernatants. Plates were then washed four
times with phosphate-buffered saline with 0.05% Tween and then
incubated with biotinylated MAb anti-IL-4, anti-IL-5, or anti-IFN-
antibody for 4 h. At the end of this period, the plates were
washed four times and incubated for 2 h with a dilution of
alkaline phosphatase-conjugated streptavidin. Finally, plates were
washed again four times, and the alkaline phosphatase activity was
revealed by adding p-nitrophenyl phosphate (Sigma). The
absorbancy was read at 495 nm in a plate reader (Bio-Rad). The
sensitivity of the titration assays were 20 pg/ml.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
by these clones was assessed.
Almost all clones produced IL-4, IL-5, and IFN-
(Fig.
1); thus, most of them did not exhibit a
fully polarized Th1 or Th2 phenotype; however, spTCC from the two study
groups differed markedly in two aspects: first, TCC from homozygous
resistant subjects produced significantly (P < 0.01)
more IL-4 (4,700 to 14,000 pg/ml versus 120 to 760 pg/ml; all geometric
means) and more IL-5 (66,000 to 226,000 pg/ml versus 70 to 2,560 pg/ml)
than did spTCC from homozygous susceptible individuals (Fig. 1).
Second, the pattern of IL-4, IL-5, and IFN-
secretion was
characteristic of each group: resistant subjects yielded clones
producing more IL-4 and IL-5 than IFN-
, whereas IFN-
was produced
in greater quantities than IL-4 and IL-5 by spTCC from susceptible
subjects. No consistent difference was recorded between the amounts of
IFN-
produced by TCC from the two study groups. No significant
correlation was observed between the ability of TCC to proliferate and
their cytokine secretion profiles.

View larger version (12K):
[in a new window]
FIG. 1.
Production of IL-4, IL-5, and IFN-
by
parasite-specific CD4+ TCC from resistant (left) and
susceptible (right) individuals. Boxes represent the 25th to 75th
centiles, and vertical bars represent the 10th to the 90th centiles of
the mean of one or two duplicate determinations performed on culture
supernatants of each TCC stimulated by anti-CD3 plus PMA. Horizontal
lines are the median values. The numbers of clones were 7, 11, 7, 13, 11, and 9 for subjects R1, R2, R3, S1, S2, and S3, respectively.
Genetic susceptibility to schistosome infection is associated with
Th0/1 or Th1 TCC.
Cytokine ratios are presented in Fig.
2 for spTCC from resistant and
susceptible subjects. On average IL-4/IFN-
ratios of spTCC from
susceptible subjects varied from 0.12 to 0.44 (geometric mean) and were
10 to 100 times lower than those of resistant subjects, which varied
from 3.7 to 12. Likewise, IL-5/IFN-
ratios for spTCC from
susceptible subjects varied from 3.6 to 12, whereas the average values
for spTCC from resistant subjects varied from 40 to 188. Tumor necrosis
factor beta (TNF-
) levels measured in the supernatants of spTCC did
not differ consistently between TCC from both study groups (data not
show).
|
Phenotypes of TCC of unknown specificity.
The cloning
procedure allows for the emergence of clones that are not specific for
parasite antigen (uspTCC); the phenotypes of uspTCC from two resistant
(R1 and R3) and two susceptible (S1 and S2) subjects were studied.
Levels of IL-4, IL-5, and IFN-
production by uspTCC from S1 and S2
were comparable to the observations made with spTCC from the same
susceptible subjects (data not shown). TCC of unknown specificity from
R3 were comparable to spTCC from the same subjects; they produced
comparable (P > 0.2) amounts of IL-4 (2,400 versus
7,000 pg/ml) and IL-5, (85,000 versus 158,000 pg/ml). However, uspTCC
from the R1 subject exhibited a phenotype closer to that of TCC from
the susceptible subjects: they produced less IL-4 (930 versus 14,400 pg/ml; P = 0.003) and less IL-5 (3,700 versus 226,000 pg/ml; P = 0.04) than spTCC from the same subjects (Fig. 3). Specific TCC and uspTCC from R1
and R3 produced, however, comparable amounts of TNF-
and IFN-
(data not shown). These findings are consistent with the conclusion
that spTCC of resistant and susceptible individuals differ in IL-4 and
IL-5 production, but not in IFN-
production.
|
| |
DISCUSSION |
|---|
|
|
|---|
Human susceptibility to S. mansoni infections is controlled by the SM1 locus in the 5q31-q33 region (2, 10, 19). This genetic region encodes several cytokines that regulate the differentiation of Th1 and Th2 lymphocytes. A clonal analysis of CD4+ T lymphocytes in resistant and susceptible subjects has been undertaken to evaluate whether this genetic control is acting on Th1/Th2 pathways.
Of 121 CD4+ TCC from three susceptible and three resistant
subjects, 68 proliferated when stimulated by parasite antigen.
Parasite-specific TCC derived from susceptible subjects (33 STCC)
produced 10- to 1,000-fold less IL-4 and IL-5 than TCC from resistant
subjects (25 RTCC). Clones from both patient groups, however, produced the same amount of IFN-
. Parasite-specific STCC were Th1 or Th0/1, whereas RTCC were Th2 or Th0/2.
Precursors of Th cells require several signals to engage a Th2
development program; critical signals are delivered by antigen and by
IL-4 (reviewed in reference 22). The effect of IL-4
is essential during the initiation of the immune response. Helminth antigens and allergens have a selective ability to release IL-4 from
various sources, including from NK1+ subsets of
CD4+ T cells (reviewed in reference 3),
mast cells, eosinophils, and basophils (reviewed in reference
23), and Lack-specific CD4+ T cells
(17). The IL-4 polarizing effect on the Th lymphocyte response is dominant over the effects of the Th1 polarizing cytokines, IL-12 and IFN-
(16, 27). Thus, when IL-4 levels are below a certain threshold, Th cells will proceed into the Th1 pathway.
The observation that R1 TCC are Th2 when they are specific for schistosome antigen and are Th1 when they are not specific for parasite antigen further confirms that schistosome antigen has a selective ability to turn on the Th2 pathway during the course of the infection, thus indicating that infections by schistosome produce the appropriate cytokine environment for Th2 development. This effect may be so marked that a normal Th1 response to a conventional antigen may, in certain subjects, deviate toward a Th2 response (26). This is probably the case in R3 subjects, who produced uspTCC with a Th0/2 phenotype. The observation that spTCC from susceptible subjects are Th0/1 or Th1 indicate that Th cells from these subjects fail to engage in Th2 development when they are stimulated by antigens that initiate the Th2 development program in most individuals. Since we linked this property to the 5q31-q33 region, it is most likely that this phenomenon is related to the cytokine environment in which T cells develop in susceptible subjects. Differences in the cytokine environment in resistant and susceptible subjects could be produced by certain polymorphisms in IL-4 or IL-12 (eventually IL-13) genes that could modify the level of production of these cytokines.
The genetic model obtained by segregation analysis is that of major locus with biallellic gene(s). Until the molecular analysis of the susceptibility locus is completed, it is not possible to decide between a simple biallellic model and more-complex models involving more than two alleles at the susceptibility locus. The fact that cytokine ratios follow a rather continuous distribution between resistant and susceptible subjects could indicate the presence of several alleles of susceptibility producing more than one susceptible genotype. It is also possible that the penetrance of the susceptible allele(s) may vary between study subjects, depending on the effects of covariates such as age or exposure.
In conclusion, the results presented in this study, together with the mapping of the SM1 locus to the human 5q31-q33, indicate that genetic control of infection by schistosomes is linked to the differentiation of Th2 lymphocytes. These findings, taken together, suggest that SM1 could play a key role in other infectious diseases that are dependent on the balance between type 1 and type 2 cytokines. Along this line, we have reported that the 5q31-33 region is also involved in the control of blood parasitemia by Plasmodium falciparum (12).
| |
ACKNOWLEDGMENTS |
|---|
This work received financial assistance from INSERM, FAPEMIG, and CNPq; from the UNDP/World Bank/WHO special program for research and training in parasitic diseases, and from the STD European program.
V.R. and K.P. contributed equally to this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: INSERM U399, Faculté de Médecine de Marseille, 27 Blvd. Jean Moulin, 13385 Marseille, Cedex 5, France. Phone: 04-91-32-44-53. Fax: 04-91-79-60-63. E-mail: Alain.Dessein{at}medecine.univ-mrs.fr.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793[Medline]. |
| 2. | Abel, L., F. Demenais, A. Prata, A. E. Souza, and A. Dessein. 1991. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am. J. Hum. Genet. 48:959-970[Medline]. |
| 3. | Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562[Medline]. |
| 4. | Butterworth, A. E., M. Capron, J. S. Cordingley, P. R. Dalton, D. W. Dunne, H. C. Kariuki, G. Kimani, D. Koech, M. Mugambi, J. H. Ouma, et al. 1985. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79:393-408[Medline]. |
| 5. | Butterworth, A. E., P. R. Dalton, D. W. Dunne, M. Mugambi, J. H. Ouma, B. A. Richardson, T. K. Siongok, and R. F. Sturrock. 1984. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Trans. R. Soc. Trop. Med. Hyg. 78:108-123[Medline]. |
| 6. | Butterworth, A. E., R. F. Sturrock, V. Houba, A. A. Mahmoud, A. Sher, and P. H. Rees. 1975. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature 256:727-729[Medline]. |
| 7. | Couissinier-Paris, P., and A. J. Dessein. 1995. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 25:2295-2302[Medline]. |
| 8. | Demeure, C. E., P. Rihet, L. Abel, M. Ouattara, A. Bourgois, and A. J. Dessein. 1993. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168:1000-1008[Medline]. |
| 9. | Dessein, A. J., M. Begley, C. Demeure, D. Caillol, J. Fueri, M. G. dos Reis, Z. A. Andrade, A. Prata, and J. C. Bina. 1988. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140:2727-2736[Abstract]. |
| 10. | Dessein, A. J., P. Couissinier, C. Demeure, P. Rihet, S. Kohlstaedt, D. Carneiro-Carvalho, M. Ouattara, V. Goudot-Crozel, H. Dessein, A. Bourgois, et al. 1992. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol. Invest. 21:423-453[Medline]. |
| 11. | Dunne, D. W., A. E. Butterworth, A. J. Fulford, J. H. Ouma, and R. F. Sturrock. 1992. Human IgE responses to Schistosoma mansoni and resistance to reinfection. Mem. Inst. Oswaldo Cruz 87:99-103. |
| 12. | Garcia, A., S. Marquet, B. Bucheton, D. Hillaire, M. Cot, N. Fievet, A. J. Dessein, and L. Abel. 1998. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J. Trop. Med. Hyg. 58:705-709[Abstract]. |
| 13. | Grogan, J. L., P. G. Kremsner, A. M. Deelder, and M. Yazdanbakhsh. 1998. Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J. Infect. Dis. 177:1433-1437[Medline]. |
| 14. | Hagan, P., U. J. Blumenthal, D. Dunn, A. J. Simpson, and H. A. Wilkins. 1991. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349:243-245[Medline]. |
| 15. | Hagan, P., H. A. Wilkins, U. J. Blumenthal, R. J. Hayes, and B. M. Greenwood. 1985. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7:625-632[Medline]. |
| 16. |
Hsieh, C. S.,
S. E. Macatonia,
C. S. Tripp,
S. F. Wolf,
A. O'Garra, and K. M. Murphy.
1993.
Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
Science
260:547-549 |
| 17. |
Julia, V.,
M. Rassoulzadegan, and N. Glaichenhaus.
1996.
Resistance to Leishmania major induced by tolerance to a single antigen.
Science
274:421-423 |
| 18. | King, C. L., and T. B. Nutman. 1992. Biological role of helper T-cell subsets in helminth infections. Chem. Immunol. 54:136-165[Medline]. |
| 19. | Marquet, S., L. Abel, D. Hillaire, H. Dessein, J. Kalil, J. Feingold, J. Weissenbach, and A. J. Dessein. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:181-184[Medline]. |
| 20. | Medhat, A., M. Shehata, K. Bucci, S. Mohamed, A. D. Dief, S. Badary, H. Galal, M. Nafeh, and C. L. King. 1998. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J. Infect. Dis. 178:512-519[Medline]. |
| 21. | Muller-Myhsok, B., F. F. Stelma, F. Guisse-Sow, B. Muntau, T. Thye, G. D. Burchard, B. Gryseels, and R. D. Horstmann. 1997. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni. Am. J. Hum. Genet. 61:452-454[Medline]. |
| 22. | O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275-283[Medline]. |
| 23. | Paul, W. E., R. A. Seder, and M. Plaut. 1993. Lymphokine and cytokine production by Fc epsilon R1+ cells. Adv. Immunol. 53:1-29[Medline]. |
| 24. | Rihet, P., C. E. Demeure, A. Bourgois, A. Prata, and A. J. Dessein. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:2679-2686[Medline]. |
| 25. |
Roberts, M.,
A. E. Butterworth,
G. Kimani,
T. Kamau,
A. J. Fulford,
D. W. Dunne,
J. H. Ouma, and R. F. Sturrock.
1993.
Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection.
Infect. Immun.
61:4984-4993 |
| 26. | Sabin, E. A., M. I. Araujo, E. M. Carvalho, and E. J. Pearce. 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173:269-272[Medline]. |
| 27. | Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673[Medline]. |
| 28. | Vadas, M. A., J. R. David, A. E. Butterworth, V. Houba, R. F. Sturrock, L. David, R. Herson, T. A. Siongok, and R. Kimani. 1980. Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections. Clin. Exp. Immunol. 39:683-694[Medline]. |
| 29. | Wierenga, E. A., M. Snoek, H. M. Jansen, J. D. Bos, R. A. van Lier, and M. L. Kapsenberg. 1991. Human atopen-specific types 1 and 2 T helper cell clones. J. Immunol. 147:2942-2949[Abstract]. |
| 30. | Wilkins, H. A., U. J. Blumenthal, P. Hagan, R. J. Hayes, and S. Tulloch. 1987. Resistance to reinfection after treatment of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 81:29-35[Medline]. |
| 31. | Wilkins, H. A., P. H. Goll, T. F. Marshall, and P. J. Moore. 1984. Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection. Trans. R. Soc. Trop. Med. Hyg. 78:227-232[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»